Human somatic cell gene therapy

BioEssays

Volumn 18, Issue 12, 1996, Pages 999-1007

  Bank, Arthur ^a  

^a Hammer Health Sciences Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030462067     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950181210     Document Type: Review

References (84)

1. Touchette, N. (1996). Gene therapy: Not ready for prime time. Nature Med. 2, 7-8.
2. Frledmann, T. (1996). Human gene therapy: An immature genie, but certainly out of a bottle. Nature Med. 2, 144-147.
3. Thomas, K.R. and Capecchi, M.R. (1987). Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-12.
4. Capecchi, M.R. (1989). Altering the genome by homologous recombination Science 244, 1288-92.
5. Yoon, K., Cole-Strauss, A. and Kmiec, E.B. (1996). Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA-DNA oligonucleotide. Proc. Natl Acad. Sci. 93, 2071-2076.
6. Miller, A. (1990). Progress toward human gene therapy. Blood 76, 271-78.
7. Smith, A. (1995). Viral vectors in gene therapy. Annu. Rev. Microbiol. 49, 807-838.
8. Crystal, R.G. (1995). Transfer of genes to humans: early lessons and obstacles to success. Science 270, 404-10.
9. Crystal, R.G. et al. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genetics 8, 42-51.
10. Wilson, J.M. (1996). Adenoviruses as gene-delivery vehicles. New Eng. J. Med. 334, 1185-89.
11. Samulskl, R.J., Chang, L.S. and Shenk, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63, 3822-8.
12. Samulskl, R.J. et al. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. [Published erratum appears in EMBO J. (1992) 11, 1228]. EMBO J. 10, 3941-50.
13. Rolling, F. and Samulskl, R.J. (1995). AAV as a viral vector for human gene therapy. Generation of recombinant virus. Mol. Biotechnol. 3, 9-15.
14. Bank, A., Ward, M., Richardson, C., Podda, S., Smith, L. and Hesdorffer, C. (1995). Retroviral gene transfer into hematopoietic stem cells: The human MDR gene as a model system. In Hematopoietic Stem Cells (ed. D. Levitt and R. Mertlesmann), pp. 229-243. Marcel Dekker, New York.
15. Mann, R., Mulligan, R.C. and Baltimore, D. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153-9.
16. Markowitz, D., Goff, S. and Bank, A. (1988). A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62, 1120-25.
17. Markowitz, D., Goff, S. and Bank, A. (1988). Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400-405.
18. Miller, A.D., Bender, M.A., Harris, E.A.S. and et al (1988). Design of retrovirus vectors for transfer and expression of the human beta globin gene. J. Virol. 62, 4337-45.
19. Weiss, R. and Tailor, C. (1995). Retrovirus receptors. Cell 82, 531-533.
20. Donahue, R.E., et al. (1992). Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176.
21. Miller, A.D. and Buttimore, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
22. Danos, O. and Mulligan, R.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl Acad. Sci. USA 85, 6460-4.
23. Blaese, R.M. et al. (1995). T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270, 475-80.
24. Wilson, J.M., Johnston, D.E., Jefferson, D.M. and Mulligan, R.C. (1988). Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit. Proc. Natl Acad. Sci. USA 85, 4421-5.
25. Grossman, M. et al. (1994). Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. [See comments]. Nature Genetics 6, 335-41.
26. Bensinger, W.I. and Berenson, R.J. (1990). Peripheral blood and positive selection of marrow as a source of stem cells for transplantation. Prog. Clin. Biol. Res. 337, 93-8.
27. Correll, P.H. and Karlsson, S. (1994). Towards therapy of Gaucher's disease by gene transfer into hematopoietic cells. Eur. J. Haematol. 53, 253-64.
28. Walsh, C.E. et al. (1994). Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J. Clin. Invest. 94, 1440-8.
29. Fairbairn, L. et al. (1996). Long-term in vitro correction of α-L-iduronidase deficiency (Hurler syndrome) in human bone marrow. Proc. Natl Acad. Sci. USA 93, 2025-2030.
30. Sokolic, R. et al. (1996). A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of x-linked CGD by selection for MDR1 expression. Blood 87, 42-50.
31. Leboulch, P. et al. (1994). Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure. EMBO J. 13, 3065-76.
32. Sadelain, M., Wang, C.H., Antonlou, M., Grosveld, F. and Mulligan, R.C. (1995). Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. Proc. Natl Acad. Sci. USA 92, 6728-32.
33. Ren, S., Wong, B.W., Li, J., Luo, X., Wong, P.M.C. and Atweh, G.F. (1996). Production of genetically stable high-titer retroviral vectors that carry a human gamma globin gene under the control of the alpha globin locus control region. Blood 87, 2518-24.
34. Ram, Z., Walbridge, S., Shawker, T., Culver, K.W., Blaese, R.M. and Oldfield, E.H. (1994). The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J. Neurosurgery 81, 256-60.
35. Culver, K.W. and Blaese, R.M. (1994). Gene therapy for cancer. Trends Genet. 10, 174-8.
36. Rosenberg, S.A. et al. (1993). The development of gene therapy for the treatment of cancer. Ann. Surgery 218, 455-464.
37. Robbins, P.F. et al. (1995). Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J. Immunol. 154, 5944-50.
38. Salgaller, M.L., Weber, J.S., Koenig, S., Yannelli, J.R. and Rosenberg, S.A. (1994). Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Cancer Immunol. Immunotherapy 39, 105-16.
39. Pardoll, D.M. (1993). Genetically engineered tumor vaccines. Ann. NY Acad. Sci. 690, 301-10.
40. Gansbacher, H. et al. (1992). Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells. Blood 80, 2817-25.
41. Dranoff, G. et al. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl Acad. Sci. USA 90, 3539-43
42. Pardoll, D.M. (1994). Tumour antigens. A new look for the 1990s. Nature 369, 357.
43. Munro, J.M. et al. (1994). In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and the malignant cells of Hodgkin's disease. Blood 83, 793-8.
44. Matulonis, U.A. et al. (1995). Role of B7-1 in mediating an immune response to myeloid leukemia cells. Blood 85, 2507-15.
45. Wu, T.C. et al. (1995). Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc. Natl Acad. Sci. USA 92, 11671-5.
46. Surbone, A. and DeVita, V.T., Jr. (1993). Dose intensity. The neglected variable in clinical trials. Ann. NY Acad. Sci. 698, 279-88.
47. Pastan, I. and Gottesman, M.M. (1991). Multidrug resistance. Annu. Rev. Med. 42, 277-286.
48. Podda, S., et al. (1992). Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl Acad. Sci. USA 89, 9676-80.
49. Sorrentino, B.P. et al. (1992). Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257, 99-103.
50. Richardson, C., Ward, M., Podda, S. and Bank, A. (1994). Mouse letal liver cells lack functional amphotropic retroviral receptors. Blood 84, 433-439.
51. Richardson, C., Ward, M. and Bank, A. (1995). MDR gene transfer into live mice. J. Mol. Med. 73, 189-95.
52. Civin, I.C., Strauss, L.C., Broval, C., Fackler, M.J., Schwartz, J.F. and Shaper, J.H. (1984). Antigenic analysis of hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol. 133, 157-160.
53. Berenson, R.J. et al. (1990). Stem cell selection - clinical experience. Prog. Clin. Biol. Res. 333, 403-10.
54. Ward, M., et al. (1994). Transfer and expression of the human multiple drug resistance gene in human CD34+ cells. Blood 84, 1408-1414.
55. Ward, M. et al. (1996). Transfer and expression of the human MDR gene in peripheral blood progenitor cells. Clin. Cancer Res. 2, 873-876.
56. Hesdorffer, C., Antman, K., Bank, A., Fetell, M. and Mears, G. (1994). Clinical protocol: Human MDR gene transfer in patients with advanced cancer. Human Gene Therapy 5, 1151-1160.
57. Hesdorffer, C., Ward, M., Markowitz, D. and Bank, A. (1990). Efficient gene transfer in live mice using a unique retroviral packaging line. DNA Cell Biol. 9, 717-23.
58. Li, M.X. et al. (1994). Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood 83, 3403-8.
59. Allay, J.A., Dumenco, L.L., Koc, O.N., Liu, L. and Gerson, S.L. (1995). Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 85, 3342-51.
60. Magni, M., Shamma, S., Sciro, R., Mellado, W., Dalla-Favera, R. and Gianni, A.M. (1996). Induction of cyclophosphamide resistance by aldehydedehydrogenase gene transfer. Blood 87, 1097-1103.
61. Cole, S.P. et al. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-4.
62. Grant, C.E., Valdimarsson, G., Hlpfner, D.R., Almquist, K.C., Cole, S.P. and Deeley, R.G. (1994). Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54, 357-61.
63. D'Hondt, V., Caruso, M., Ward, M., Deeley, R. and Bank, A. (1995). Expression of the multidrug resistance protein (MRP) gene using retroviral vectors. Blood (suppl.) 86, 466a.
64. Nabel, G.J., Fox, B.A., Post, L., Thompson, C.B. and Woffendin, C. (1994). A molecular genetic intervention for AIDS - effects of a transdominant negative form of Rev. Human Gene Therapy 5, 79-92.
65. Woffendin, C., Ranga, U., Yang, Z.-Y., Xu, L. and Nabel, G. (1996). Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc. Natl Acad. Sci. USA 93, 2889-2894.
66. Richardson, C. and Bank, A. (1995). Preselection of transduced murine hematopoietic stem cell populations leads to increased long-term stability and expression of the human multiple drug resistance gene. Blood 86, 2579-89.
67. Peters, S.O., Kittler, E.L., Ramshaw, H.S. and Quesenberry, P.J. (1995). Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp. Hematol. 23, 461-9.
68. Peters, S.O., Kittler, E.L., Ramshaw, H.S. and Quesenberry, P.J. (1996). Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87, 30-7.
69. Bienzle, D. et al. (1994). Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation. Proc. Natl Acad. Sci. USA 91, 350-4.
70. Stewart, A.K., Dube, I.D., Kamel-Reid, S. and Keeting, A. (1995). A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma. Human Gene Therapy 6, 107-19.
71. Emerson, S. (1996). Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics. Blood 87, 3082-3088.
72. Yee, J.K., Miyanohara, A.A., Laporte, P., Boulc, K., Burns, J.C. and Friedmann, T. (1994). A general method for the generation of high-titer pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl Acad. Sci. USA 91, 9564-68.
73. Yang, Y. et al. (1995). Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Human Gene Therapy 6, 1203-1213.
74. Naldini, L. et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
75. Rigg, R., Chen, J., Dando, J., Forestell, S., Plavec, I. and Bohnlein, E. (1996). A novel human amphotropic packaging cell line: High titer, complement resistance, and improved safety. Virotogy 218, 290-295.
76. Kasahara, N., Dozy, A.M. and Kan, Y.W. (1994) Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. [See comments]. Science 266, 1373-6.
77. Somla, N., Zoppe, M. and Verma, I. (1995). Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc. Natl Acad. Sci. USA 92, 7570-7574.
78. Russell, D.W. and Miller, A.D. (1996). Foamy virus vectors. J. Virol. 70, 217-22.
79. Hofmann, C., Sandig, V., Jennings, G., Rudolph, M., Schlag, P. and Strauss, M. (1995). Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl Acad. Sci. USA 92, 10099-10103.
80. Broxmeyer, H.E., Lu, L., Gaddy, J., Ruggieri, L., Srlvastava, A. and Risdon, G. (1995). Human umbilical cord blood transplantation: The immunology, expansion, and therapeutic applications of hematopoietic stem and progenitor cells. In Hematopoietic Stem Cells (ed. D. Levitt and R. Mertlesmann), pp. 297-319. Marcel Dekker, New York.
81. Rubinstein, P. et al. (1995). Processing and cyropreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc. Natl Acad. Sci. USA 92, 10119-10122.
82. Zanjanl, E.D., Flake, A.W., Rice, H., Hedrick, M. and Tavassoli, M. (1994). Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. [See comments]. J. Clin. Invest. 93, 1051-5.
83. Zanjanl, E.D., Srour, E.F. and Hoffman, R. (1995). Retention of long-term repopulating ability of xenogeneic transplanted purified adult human bone marrow hematopoietic stem cells in sheep. J. Lab. Clin. Med. 126, 24-8.
84. Blazar, B., Taylor, P. and Vallera, D. (1995). In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T and B cell functional capabilities. Blood 86, 4353-4366.